Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

a study on Hepatitis C Hepatitis A Hepatitis

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Meghan D Morris, MPH, PhD
Headshot of Meghan D Morris
Meghan D Morris

Description

Summary

The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).

Official Title

A Randomized Trial to Test the Efficacy of a Partner Navigation Intervention for HCV Treatment Among Young Adult People Who Inject Drugs

Details

After an initial ramp-up phase to ensure intervention materials and protocols meet the needs of the target population and organizational setting, we will apply a stratified randomized design to enroll 250 adult PWID with recently diagnosed HCV infection ("index") and their primary injecting partner("partner") into a randomized control efficacy trial of a two-session partner navigation intervention, compared to standard of care. The primary endpoint is starting HCV treatment. Recruitment will over sample PWID between 18-30 years of age.

Keywords

Hepatitis C, Young people who inject drugs, Hepatitis A, Hepatitis, Partner Navigation Intervention

Eligibility

For people ages 18 years and up

Inclusion Criteria:

  • Self report injecting drugs in the past month
  • Self report a primary injecting partner (currently inject drugs together)
  • HCV infection identified at partnering community-based clinical site

Location

  • UCSF accepting new patients
    San Francisco California 94158 United States

Lead Scientist at UCSF

  • Meghan D Morris, MPH, PhD
    My professional activities are grounded in engaging diverse partners in the development of evidence-based policy change to reduce social inequalities and improve health among underserved communities.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06179498
Study Type
Interventional
Participants
Expecting 250 study participants
Last Updated
Contact us about this trial